 | Up a level |
Park, Keunchil and Janne, Pasi A. and Kim, Dong-Wan and Han, Ji-Youn and Wu, Ming-Fang and Lee, Jong-Seok and Kang, Jin-Hyoung and Lee, Dae Ho and Cho, Byoung Chul and Yu, Chong-Jen and Pang, Yong Kek and Felip, Enriqueta and Kim, Hyunjin and Baek, Eunhye and Noh, Young Su (2021) Olmutinib in T790M-positive non-small cell lung cancer after failure of first-line epidermal growth factor receptor-tyrosine kinase inhibitor therapy: A global, phase 2 study. Cancer, 127 (9). pp. 1407-1416. ISSN 0008-543X, DOI https://doi.org/10.1002/cncr.33385.
Muro, Kei and Van Cutsem, Eric and Narita, Yukiya and Pentheroudakis, George and Baba, Eishi and Li, Jin and Ryu, Min-hee and Wan Zamaniah, Wan Ishak and Yong, Wei Peng and Yeh, Kun Huei and Kato, Ken and Lu, Zhihao and Cho, Byoung Chul and Nor, I.M. and Ng, Matthew and Chen, Li Tzong and Nakajima, Takako Eguchi and Shitara, Kouhei and Kawakami, Hisato and Tsushima, Takahiro and Yoshino, Takayuki and Lordick, Florian and Martinelli, Erika and Smyth, Elizabeth C. and Arnold, Dirk and Minami, Hironobu and Tabernero, J. and Douillard, Jean Yves (2019) Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with metastatic gastric cancer: a JSMO–ESMO initiative endorsed by CSCO, KSMO, MOS, SSO and TOS. Annals of Oncology, 30 (1). pp. 19-33. ISSN 0923-7534, DOI https://doi.org/10.1093/annonc/mdy502.
Muro, Kei and Lordick, Florian and Tsushima, Takahiro and Pentheroudakis, George and Baba, Eishi and Lu, Zhihao and Cho, Byoung Chul and Nor, I.M. and Ng, Matthew and Chen, Li Tzong and Kato, Ken and Li, Jin and Ryu, Min-hee and Wan Zamaniah, Wan Ishak and Yong, Wei Peng and Yeh, Kun Huei and Nakajima, Takako Eguchi and Shitara, Kouhei and Kawakami, Hisato and Narita, Yukiya and Yoshino, Takayuki and Van Cutsem, Eric and Martinelli, Erika and Smyth, Elizabeth C. and Arnold, Dirk and Minami, Hironobu and Tabernero, J. and Douillard, Jean Yves (2019) Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with metastatic oesophageal cancer: a JSMO–ESMO initiative endorsed by CSCO, KSMO, MOS, SSO and TOS. Annals of Oncology, 30 (1). pp. 34-43. ISSN 0923-7534, DOI https://doi.org/10.1093/annonc/mdy498.
